1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow NUT Carcinoma: new trials by email Literature Review of NUT Carcinoma trials Research Report on NUT Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies EP31670 - Castrate Resistant Prostate Cancer, NUT Carcinoma | Phase 1 | Unknown | Epigenetix, Inc. | 75 | 2022-12-21 | 2025-01-14 |
| BI 894999 First in Human Dose Finding Study in Advanced Malignancies BI 894999 - Neoplasms, NUT Carcinoma | Phase 1 | Completed | Boehringer Ingelheim | 174 | 2015-07-08 | 2024-04-15 |
Leukemia, Myelomonocytic, Chronic (1) · Neoplasms (1) · Primary Myelofibrosis (1)
Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Myelodysplastic-Myeloproliferative Diseases (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Boehringer Ingelheim (1) · Epigenetix, Inc. (1)
United States (2) · Belgium (1) · France (1) · Germany (1) · South Korea (1) · Spain (1)
Judy Chiao, MD (1)
2015 (1)